DK149589A - Dna-sekvens, dna-vektor, muteret hiv-virusgenom, hiv-vaccine og fremgangsmaade til fremstilling af samme - Google Patents

Dna-sekvens, dna-vektor, muteret hiv-virusgenom, hiv-vaccine og fremgangsmaade til fremstilling af samme

Info

Publication number
DK149589A
DK149589A DK149589A DK149589A DK149589A DK 149589 A DK149589 A DK 149589A DK 149589 A DK149589 A DK 149589A DK 149589 A DK149589 A DK 149589A DK 149589 A DK149589 A DK 149589A
Authority
DK
Denmark
Prior art keywords
pyrazole compounds
analogy process
preparing polycyclic
polycyclic
preparing
Prior art date
Application number
DK149589A
Other languages
Danish (da)
English (en)
Other versions
DK149589D0 (da
Inventor
Joseph Mccrary Mccune
Original Assignee
Univ Leland Stanford Junior
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Leland Stanford Junior filed Critical Univ Leland Stanford Junior
Publication of DK149589D0 publication Critical patent/DK149589D0/da
Publication of DK149589A publication Critical patent/DK149589A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK149589A 1988-03-28 1989-03-28 Dna-sekvens, dna-vektor, muteret hiv-virusgenom, hiv-vaccine og fremgangsmaade til fremstilling af samme DK149589A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US17400588A 1988-03-28 1988-03-28

Publications (2)

Publication Number Publication Date
DK149589D0 DK149589D0 (da) 1989-03-28
DK149589A true DK149589A (da) 1989-09-29

Family

ID=22634418

Family Applications (1)

Application Number Title Priority Date Filing Date
DK149589A DK149589A (da) 1988-03-28 1989-03-28 Dna-sekvens, dna-vektor, muteret hiv-virusgenom, hiv-vaccine og fremgangsmaade til fremstilling af samme

Country Status (5)

Country Link
EP (1) EP0335635A1 (fr)
JP (1) JPH029372A (fr)
AU (1) AU3170089A (fr)
DK (1) DK149589A (fr)
IL (1) IL89567A0 (fr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02203783A (ja) * 1989-02-02 1990-08-13 Banyu Pharmaceut Co Ltd 抗原性を有する非感染性エイズウイルス産生クローン化ヒトｔ細胞
GB8923123D0 (en) * 1989-10-13 1989-11-29 Connaught Lab A vaccine for human immunodeficiency virus
US5861282A (en) * 1989-10-16 1999-01-19 Whitehead Institute For Biomedical Research Non-infectious HIV particles and uses therefor
US7041293B1 (en) 1990-04-03 2006-05-09 Genentech, Inc. HIV env antibodies
JP3494300B2 (ja) * 1990-04-03 2004-02-09 ジェネンテック・インコーポレーテッド Ｈｉｖに対する予防接種のための方法および組成物
EP0537247A4 (en) * 1990-06-19 1993-09-08 Immuvax Nonpathogenic variant virus
GB9106048D0 (en) * 1991-03-21 1991-05-08 Smithkline Beecham Biolog Vaccines
CA2092827A1 (fr) * 1990-09-28 1992-03-29 Smithkline Beecham Biologicals S.A. Derives de la gp160 et vaccins bases sur la gp160 ou son derive, contenant un adjuvant
ES2115622T5 (es) * 1990-10-17 2003-03-16 Us Health Clones moleculares de hiv-1 y usos de los mismos.
FR2676071B1 (fr) * 1991-05-02 1994-11-18 Transgene Sa Nouveau variant gp160 non-clivable, soluble, de forme hybride.
WO1993020206A1 (fr) * 1992-03-27 1993-10-14 International Flower Developments Pty. Ltd. Sequences genetiques codant des enzymes d'acces des flavonoides et utilisations de ces sequences
US6174666B1 (en) 1992-03-27 2001-01-16 The United States Of America As Represented By The Department Of Health And Human Services Method of eliminating inhibitory/instability regions from mRNA
GB9215233D0 (en) * 1992-07-17 1992-09-02 Pitman Moore Inc Vaccines
WO1994016081A1 (fr) * 1993-01-16 1994-07-21 Manfred Schawaller Procede permettant d'obtenir des domaines natifs de proteines virales membranaires, leur utilisation, notamment comme vaccin contre le vih
WO1994028929A1 (fr) 1993-06-07 1994-12-22 Genentech, Inc. Polypeptides d'enveloppe du vih
US5795737A (en) * 1994-09-19 1998-08-18 The General Hospital Corporation High level expression of proteins
US6585979B1 (en) 1996-07-08 2003-07-01 Genentech, Inc. HIV envelope polypeptides and immunogenic composition
US6114148C1 (en) * 1996-09-20 2012-05-01 Gen Hospital Corp High level expression of proteins
EP2388015A1 (fr) * 2000-03-02 2011-11-23 Emory University Vecteurs d'expression de l'ADN et procédés d'utilisation
US8623379B2 (en) 2000-03-02 2014-01-07 Emory University Compositions and methods for generating an immune response
JP5052732B2 (ja) 2000-08-14 2012-10-17 アメリカ合衆国 遺伝的免疫化のための免疫原性を強化するＨＩＶＥｎｖ、Ｇａｇ、およびＰｏｌの改変
JP4554887B2 (ja) 2001-03-08 2010-09-29 アメリカ合衆国 改変ＨＩＶエンベロープ、ｇａｇ、およびｐｏｌ遺伝子を発現するＭＶＡ
WO2003059385A2 (fr) * 2002-01-14 2003-07-24 Chiron Corporation Vaccin contre le vih et procede d'utilisation
CN103797029B (zh) 2011-05-17 2016-08-17 洛克菲勒大学 人类免疫缺陷病毒中和抗体及其使用方法
WO2014039561A1 (fr) * 2012-09-04 2014-03-13 Mbio Diagnostics, Inc. Système et procédé d'amélioration du dosage de biomarqueurs

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2606029B2 (fr) * 1986-04-08 1989-02-03 Transgene Sa Vecteur viral et adn recombinant codant pour une glycoproteine du virus agent causal du s.i.d.a., culture cellulaire infectee par ce vecteur, procede de preparation de la glycoproteine, glycoproteine obtenue, vaccin et anticorps obtenus
JPS63258575A (ja) * 1986-12-15 1988-10-26 レプリゲン　コーポレーション 昆虫細胞中でつくられる組換えｈｉｖエンベロープタンパク

Also Published As

Publication number Publication date
IL89567A0 (en) 1989-09-10
JPH029372A (ja) 1990-01-12
DK149589D0 (da) 1989-03-28
EP0335635A1 (fr) 1989-10-04
AU3170089A (en) 1989-09-28

Similar Documents

Publication Publication Date Title
DK149589A (da) Dna-sekvens, dna-vektor, muteret hiv-virusgenom, hiv-vaccine og fremgangsmaade til fremstilling af samme
GB2257149B (en) Process for preparing polyoxyalkylene- or alkylpolyglucoside- carboxylates
AU8225491A (en) Process for preparing dibenzylidene-d-sorbitol compounds
HU907100D0 (en) Process for producing cephalosporine derivatives
SG48341A1 (en) Process for preparing benzopyran compounds
HUT52487A (en) Process for producing mono-n-alkyl-polyaza-makroring compounds
YU24088A (en) Process for preparing heterocyclical compounds
GB2216519B (en) Process for preparing n-sulphonyl-ureas
IL88943A0 (en) Process for preparing 1-alkyl-5-nitroimidazoles
HU905944D0 (en) Process for producing new macrolidic compounds
GB2222403B (en) Process for preparing 2-methoxyisobutylisonitrile
CZ70895A3 (en) Process for preparing substituted 5-formylimidazole compounds
EP0503294A3 (en) Process for preparing perfluorpolyetheracrylfluorides
EP0341063A3 (en) Process for preparing 5-c-hydroxymethyl aldohexose-based compounds
LTIP349A (en) Process for preparing trijodobenzene compounds
AU7471791A (en) Process for preparing hydroxyalkyl-1 nitro-5 imidazoles
LTIP847A (en) Process for preparing imidazole derivatives
PT84492A (en) Process for preparing gametocidal pyrazoles
ZA925560B (en) Process for preparing 13alpha-cinnamoyl-baccatine iii or-10-deacetyl-baccatine iii
YU81090A (en) Process for preparing polycyclical compounds
YU146589A (en) Process for preparing new alylaminoethyl-azoles
PT86534A (en) Process for preparing 2-heterocyclylalkyl-2-penem compounds
GB2223232B (en) Process for preparing sulphoxide containing compounds
IL104398A0 (en) Process for preparing substituted 2-cyanopyridines
IL103261A0 (en) Process for preparing 4-chlorobenzotrichloride

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment